A “shift” in the government’s COVID vaccine policy?

In a set of documents released yesterday, the FDA announced that its Vaccine and Related Biological Products Advisory Committee (VRBPAC) will vote Thursday on what’s being described as a “major shift” in the government’s COVID vaccine strategy. Some of the people who have been sounding the alarm over the vaccines recently, particularly the latest boosters, may read that news and suspect that some good news may be on the horizon. But looking deeper into the preview of the policy, it’s not very different from the long-term strategy that Washington has been pushing all along.Read More